Brett also introduces the collaborative efforts of Reason for Hope's team, which includes strategic minds from various fields, working together in drafting legislation, preparing legal briefings, educating legislators, and building advocacy coalitions. Currently, Reason for Hope focuses on establishing MDMA- and psilocybin-assisted therapy expanded access pilot programs for those unable to wait for FDA approval.
Big Pharma Steps Onto the Psychedelics Wagon
Business‘Psilocybin Has Been Extremely Effective’: Firefighter Advocates for Decriminalization
PolicyPsilocybin v. Escitalopram: Study Compares Effects on Depression
ResearchOver One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment
ResearchNASA-Inspired Psychedelic Odyssey: Artechouse’s ‘Beyond the Light’ Exhibit Is a Spacetime Trip
Culture, EducationThe Biggest Psychedelic News Stories of the Week – August 21st
Business, PolicyRemoving Barriers of Accessibility to Psychedelics with Brett Waters
PodcastsNew Study Will Investigate Psilocybin Therapy for Gambling Addiction
Research30 Days, 30 Psychedelic Retreats – Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds
Culture, TreatmentCanadian Psychedelic Users Self-Medicating, But Few Discuss with Healthcare Providers, Says Recent Survey
Culture, Research